299 related articles for article (PubMed ID: 22801960)
1. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27.
Salzer E; Daschkey S; Choo S; Gombert M; Santos-Valente E; Ginzel S; Schwendinger M; Haas OA; Fritsch G; Pickl WF; Förster-Waldl E; Borkhardt A; Boztug K; Bienemann K; Seidel MG
Haematologica; 2013 Mar; 98(3):473-8. PubMed ID: 22801960
[TBL] [Abstract][Full Text] [Related]
2. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia.
van Montfrans JM; Hoepelman AI; Otto S; van Gijn M; van de Corput L; de Weger RA; Monaco-Shawver L; Banerjee PP; Sanders EA; Jol-van der Zijde CM; Betts MR; Orange JS; Bloem AC; Tesselaar K
J Allergy Clin Immunol; 2012 Mar; 129(3):787-793.e6. PubMed ID: 22197273
[TBL] [Abstract][Full Text] [Related]
3. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.
Abolhassani H; Edwards ES; Ikinciogullari A; Jing H; Borte S; Buggert M; Du L; Matsuda-Lennikov M; Romano R; Caridha R; Bade S; Zhang Y; Frederiksen J; Fang M; Bal SK; Haskologlu S; Dogu F; Tacyildiz N; Matthews HF; McElwee JJ; Gostick E; Price DA; Palendira U; Aghamohammadi A; Boisson B; Rezaei N; Karlsson AC; Lenardo MJ; Casanova JL; Hammarström L; Tangye SG; Su HC; Pan-Hammarström Q
J Exp Med; 2017 Jan; 214(1):91-106. PubMed ID: 28011864
[TBL] [Abstract][Full Text] [Related]
4. Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event.
Burns DM; Tierney R; Shannon-Lowe C; Croudace J; Inman C; Abbotts B; Nagra S; Fox CP; Chaganti S; Craddock CF; Moss P; Rickinson AB; Rowe M; Bell AI
Blood; 2015 Dec; 126(25):2665-75. PubMed ID: 26450987
[TBL] [Abstract][Full Text] [Related]
5. Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency.
Alkhairy OK; Perez-Becker R; Driessen GJ; Abolhassani H; van Montfrans J; Borte S; Choo S; Wang N; Tesselaar K; Fang M; Bienemann K; Boztug K; Daneva A; Mechinaud F; Wiesel T; Becker C; Dückers G; Siepermann K; van Zelm MC; Rezaei N; van der Burg M; Aghamohammadi A; Seidel MG; Niehues T; Hammarström L
J Allergy Clin Immunol; 2015 Sep; 136(3):703-712.e10. PubMed ID: 25843314
[TBL] [Abstract][Full Text] [Related]
6. Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.
Alosaimi MF; Hoenig M; Jaber F; Platt CD; Jones J; Wallace J; Debatin KM; Schulz A; Jacobsen E; Möller P; Shamseldin HE; Abdulwahab F; Ibrahim N; Alardati H; Almuhizi F; Abosoudah IF; Basha TA; Chou J; Alkuraya FS; Geha RS
J Allergy Clin Immunol; 2019 Aug; 144(2):574-583.e5. PubMed ID: 30872117
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of Epstein-Barr Virus Infection in Hypomorphic ZAP70 Mutation.
Hoshino A; Takashima T; Yoshida K; Morimoto A; Kawahara Y; Yeh TW; Okano T; Yamashita M; Mitsuiki N; Imai K; Sakatani T; Nakazawa A; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Kojima S; Morio T; Kanegane H
J Infect Dis; 2018 Jul; 218(5):825-834. PubMed ID: 29684201
[TBL] [Abstract][Full Text] [Related]
8. When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.
Sacco KA; Notarangelo LD; Delmonte OM
Clin Microbiol Infect; 2023 Apr; 29(4):457-462. PubMed ID: 36209991
[TBL] [Abstract][Full Text] [Related]
9. Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection.
Malbran A; Belmonte L; Ruibal-Ares B; Baré P; Massud I; Parodi C; Felippo M; Hodinka R; Haines K; Nichols KE; de Bracco MM
Blood; 2004 Mar; 103(5):1625-31. PubMed ID: 14604960
[TBL] [Abstract][Full Text] [Related]
10. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency.
Ghosh S; Köstel Bal S; Edwards ESJ; Pillay B; Jiménez Heredia R; Erol Cipe F; Rao G; Salzer E; Zoghi S; Abolhassani H; Momen T; Gostick E; Price DA; Zhang Y; Oler AJ; Gonzaga-Jauregui C; Erman B; Metin A; Ilhan I; Haskologlu S; Islamoglu C; Baskin K; Ceylaner S; Yilmaz E; Unal E; Karakukcu M; Berghuis D; Cole T; Gupta AK; Hauck F; Kogler H; Hoepelman AIM; Baris S; Karakoc-Aydiner E; Ozen A; Kager L; Holzinger D; Paulussen M; Krüger R; Meisel R; Oommen PT; Morris E; Neven B; Worth A; van Montfrans J; Fraaij PLA; Choo S; Dogu F; Davies EG; Burns S; Dückers G; Becker RP; von Bernuth H; Latour S; Faraci M; Gattorno M; Su HC; Pan-Hammarström Q; Hammarström L; Lenardo MJ; Ma CS; Niehues T; Aghamohammadi A; Rezaei N; Ikinciogullari A; Tangye SG; Lankester AC; Boztug K
Blood; 2020 Dec; 136(23):2638-2655. PubMed ID: 32603431
[TBL] [Abstract][Full Text] [Related]
11. CD27: a new player in the field of common variable immunodeficiency and EBV-associated lymphoproliferative disorder?
Seidel MG
J Allergy Clin Immunol; 2012 Apr; 129(4):1175; author reply 1175-6. PubMed ID: 22365582
[No Abstract] [Full Text] [Related]
12. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
Front Immunol; 2018; 9():2400. PubMed ID: 30386345
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation.
Moshous D; Martin E; Carpentier W; Lim A; Callebaut I; Canioni D; Hauck F; Majewski J; Schwartzentruber J; Nitschke P; Sirvent N; Frange P; Picard C; Blanche S; Revy P; Fischer A; Latour S; Jabado N; de Villartay JP
J Allergy Clin Immunol; 2013 Jun; 131(6):1594-603. PubMed ID: 23522482
[TBL] [Abstract][Full Text] [Related]
14. NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.
Boztug H; Hirschmugl T; Holter W; Lakatos K; Kager L; Trapin D; Pickl W; Förster-Waldl E; Boztug K
J Clin Immunol; 2016 Aug; 36(6):533-40. PubMed ID: 27338827
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
16. [Lymphoproliferative disorders and inborn errors of immunity].
Doi T; Okada S
Rinsho Ketsueki; 2020; 61(9):1365-1372. PubMed ID: 33162537
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
18. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
Huck K; Feyen O; Niehues T; Rüschendorf F; Hübner N; Laws HJ; Telieps T; Knapp S; Wacker HH; Meindl A; Jumaa H; Borkhardt A
J Clin Invest; 2009 May; 119(5):1350-8. PubMed ID: 19425169
[TBL] [Abstract][Full Text] [Related]
19. Novel mutation in the CD27 gene in a patient presenting with hypogammaglobulinemia, bronchiectasis and EBV-driven lymphoproliferative disease.
Kishore R; Gupta A; Gupta AK; Kabra SK
BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32041749
[TBL] [Abstract][Full Text] [Related]
20. The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.
Yamamoto N; Nishimura N; Takeuchi M; Ito T; Yokozaki H; Hirase S; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Nishio H; Matsuo M; Imadome K; Iijima K
Eur J Pediatr; 2014 Dec; 173(12):1615-8. PubMed ID: 24169729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
